Skip to main content
Log in

An Update on Tourette Syndrome

  • Published:
Current Neurology and Neuroscience Reports Aims and scope Submit manuscript

Abstract

Recent advances in our understanding of the phenomenology, etiology, pathophysiology, and treatment of Tourette syndrome are discussed. Tourette syndrome appears to involve dysfunction of limbic and somatosensory “traffic” through the basal ganglia, within corticostriatal-thalamocortical circuits. Dynamic alterations in the balance of these inputs may dictate the manifestations (sensory, motor, affective, and behavioral) of the disorder at any given time. Individualized assessment and treatment are the keys to optimal treatment of this condition.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Pauls DL, Cohen DJ, Heimbuch R, et al.: Familial pattern and transmission of Gilles de la Tourette syndrome and multiple tics. Arch Gen Psychiatry 1981, 38:1091–1093.

    CAS  PubMed  Google Scholar 

  2. Hebebrand J, Klug B, Fimmers R, et al.: Rates for tic disorders and obsessive compulsive symptomatology in families of children and adolescents with Gilles de la Tourette syndrome. J Psychiatr Res 1997, 31:519–530.

    Article  CAS  PubMed  Google Scholar 

  3. Price RA, Kidd KK, Cohen DJ, et al.: A twin study of Tourette syndrome. Arch Gen Psychiatry 1985, 42:815–820.

    CAS  PubMed  Google Scholar 

  4. Tourette Syndrome Association International Consortium for Genetics: Genome scan for Tourette disorder in affected-sibling-pair and multigenerational families. Am J Hum Genet 2007, 80:265–272.

    Article  Google Scholar 

  5. Abelson JF, Kwan KY, O’Roak BJ, et al.: Sequence variants in SLITRK1 are associated with Tourette’s syndrome. Science 2005, 310:317–320.

    Article  CAS  PubMed  Google Scholar 

  6. Simonic I, Nyholt DR, Gericke GS, et al.: Further evidence for linkage of Gilles de la Tourette syndrome (GTS) susceptibility loci on chromosome 2p11, 8q22 and 11q23-24 in South African Afrikaners. Am J Med Genet 2001, 105(2):163–167.

    Article  CAS  PubMed  Google Scholar 

  7. Merette C, Brassard A, Potvin A ,et al.: Significant linkage for Tourette syndrome in a large French Canadian family. Am J Hum Genet 2000, 67(4):1008–1013.

    Article  CAS  PubMed  Google Scholar 

  8. Diaz-Anzaldua A, Riviere J-B, Dube M-P, et al.: Chromosome 11-q24 region in Tourette syndrome: association and linkage disequilibrium study in the French Canadian population. Am J Med Genet Part A 2005, 138A(3):225–228.

    Article  PubMed  Google Scholar 

  9. Curtis D, Brett P, Dearlove AM, et al.: Genome scan of Tourette syndrome in a single large pedigree shows some support for linkage to regions of chromosomes 5, 10 and 13. Psychiatr Genet 2004, 14:83–87.

    Article  CAS  PubMed  Google Scholar 

  10. Mell LK, Davis RL, Owens D: Association between streptococcal infection and obsessive compulsive disorder, Tourette’s syndrome, and tic disorder. Pediatrics 2005, 116:56–60.

    Article  PubMed  Google Scholar 

  11. • Martino D, Dale RC, Gilbert DL, et al.: Immunopathogenic mechanisms in Tourette syndrome: a critical review. Mov Disord 2009, 24:1267–1279. This is a comprehensive summary of evidence for the role of infection and autoimmunity in TS.

    Article  PubMed  Google Scholar 

  12. Peterson BS, Thomas P, Kane MJ, et al.: Basal ganglia volumes in patients with Gilles de la Tourette syndrome. Arch Gen Psychiatry 2003, 60:415–424.

    Article  PubMed  Google Scholar 

  13. Bloch M, Michael H, Leckman JF, et al.: Caudate volumes in childhood predict symptom severity in adults with Tourette syndrome. Neurology 2005, 65:1253–1258.

    Article  PubMed  Google Scholar 

  14. Kalanithi PS, Zheng W, DiFiglia M, et al.: Altered parvalbumin-positive neuron distribution in basal ganglia of individuals with Tourette syndrome. Proc Natl Acad Sci U S A 2005, 102:13307–13312.

    Article  CAS  PubMed  Google Scholar 

  15. •• Mink JW: Neurobiology of basal ganglia and Tourette syndrome: basal ganglia circuits and thalamocortical outputs. Adv Neurol 2006, 99:89–98. The author proposes an elegant model to explain the link between basal ganglia neuronal activity and the clinical manifestations of TS.

    PubMed  Google Scholar 

  16. Peterson BS, Staib L, Scahill L, et al.: Regional brain and ventricular volumes in Tourette syndrome. Arch Gen Psychiatry 2001, 58:427–440.

    Article  CAS  PubMed  Google Scholar 

  17. Plessen KJ, Wentzel-Larsen T, Hugdahl K, et al.: Altered interhemispheric connectivity in individuals with Tourette’s disorder. Am J Psychiatry 2004, 161:2028–2037.

    Article  PubMed  Google Scholar 

  18. Peterson BS, Choi HA, Hao X, et al.: Morphologic features of the amygdala and hippocampus in children and adults with Tourette syndrome. Arch Gen Psychiatry 2007, 64:1281–1291.

    Article  PubMed  Google Scholar 

  19. •• Sowell ER, Kan E, Yoshii J, et al.: Thinning of sensorimotor cortices in children with Tourette syndrome. Nat Neurosci 2008, 11:6–8. This is an elegant paper on structural cortical changes in children with TS.

    Article  Google Scholar 

  20. Fahim C, Yoon U, Das S, et al.: Somatosensory-motor bodily representation cortical thinning in Tourette: effects of tic severity, age and gender. Cortex 2010, 46:750–760.

    Article  PubMed  Google Scholar 

  21. •• Thomalla G, Siebner HR, Jonas M, et al.: Structural changes in the somatosensory system correlate with tic severity in Gilles de la Tourette syndrome. Brain 2009, 132:765–777. This article confirms structural changes of the cerebral cortex and, in addition, shows a correlation between these changes and symptom severity.

    Article  PubMed  Google Scholar 

  22. Neuner I, Kupriyanova Y, Stocker T, et al.: White-matter abnormalities in Tourette syndrome extend beyond motor pathways. Neuroimage 2010, Feb 24 (Epub ahead of print; doi:10.1016/j.neuroimage.2010.02.049).

  23. Rickards H: Functional neuroimaging in Tourette syndrome. J Psychosom Res 2009, 67:575–584.

    Article  PubMed  Google Scholar 

  24. •• Bohlhalter S, Goldfine A, Matteson S, et al.: Neural correlates of tic generation in Tourette syndrome: an event-related functional MRI study. Brain 2006, 129:2029–2037. This article describes cerebral activation patterns both in the premonitory phase of tic generation and at tic onset. Heightened somatosensory and limbic activity in the premonitory phase alters abruptly at the time of tic onset.

    Article  CAS  PubMed  Google Scholar 

  25. Mochizuki H, Tashiro M, Kano M, et al.: Imaging of central itch modulation in the human brain using positron emission tomography. Pain 2003, 105:339–346.

    Article  PubMed  Google Scholar 

  26. Marsh R, Zhu H, Wang Z: A developmental fMRI study of regulatory control in Tourette’s syndrome. Am J Psychiatry 2007, 164:955–966.

    Article  PubMed  Google Scholar 

  27. • Church JA, Fair DA, Dosenbach NUF, et al.: Control networks in paediatric Tourette syndrome show immature and anomalous patterns. Brain 2009, 132:225–238. The authors present data suggesting there may be a failure of normal cerebral maturation in TS patients.

    Article  PubMed  Google Scholar 

  28. Saxena S, Brody AL, Schwartz JM, Baxter LR Jr: Neuroimaging and frontal-subcortical circuitry in obsessive-compulsive disorder. Br J Psychiatry Suppl 1998, 35:26–37.

    PubMed  Google Scholar 

  29. Morecraft RJ, Stilwell-Morecraft KS, Rossing WR: The motor cortex and facial expression: new insights from neuroscience. Neurologist 2004, 10:235–249.

    Article  PubMed  Google Scholar 

  30. Barnhill LJ Jr: Improvement in speech dysfluency in Tourette’s disorder after tongue piercing. J Am Acad Child Adolesc Psychiatry 2007, 46:3–4.

    Article  PubMed  Google Scholar 

  31. Shapiro AK, Shapiro E: Controlled study of pimozide vs placebo in Tourette’s syndrome. J Am Acad Child Adolesc Psychiatry 1984, 23:161–173.

    Article  CAS  Google Scholar 

  32. Shapiro E, Shapiro AK, Fulop G, et al.: Controlled study of haloperidol, pimozide, and placebo for the treatment of Gilles de la Tourette’s syndrome. Arch Gen Psychiatry 1989, 46:722–730.

    CAS  PubMed  Google Scholar 

  33. Sallee FR, Nesbitt L, Jackson C, et al.: Relative efficacy of haloperidol and pimozide in children and adolescents with Tourette’s disorder. Am J Psychiatry 1997, 154:1057–1062.

    CAS  PubMed  Google Scholar 

  34. Borison RL, Ang L, Chang S, et al.: New pharmacological approaches in the treatment of Tourette syndrome. Adv Neurol 1982, 35:377–382.

    CAS  PubMed  Google Scholar 

  35. Silay YS, Vuong KD, Jankovic J: The efficacy and safety of fluphenazine in patients with Tourette syndrome. Neurology 2004;62: A506.

    Google Scholar 

  36. Dion Y, Annable L, Sandor P, Chouinard G: Risperidone in the treatment of tourette syndrome: a double-blind, placebo-controlled trial. J Clin Psychopharmacol 2002, 22:31–39.

    Article  CAS  PubMed  Google Scholar 

  37. Scahill L, Leckman JF, Schultz RT, et al.: A placebo-controlled trial of risperidone in Tourette syndrome. Neurology 2003, 60:1130–1135.

    Article  CAS  PubMed  Google Scholar 

  38. Sallee FR, Kurlan R, Goetz CG, et al.: Ziprasidone treatment of children and adolescents with Tourette’s syndrome: a pilot study. J Am Acad Child Adolesc Psychiatry 2000, 39:292–299.

    Article  CAS  PubMed  Google Scholar 

  39. Eggers CH, Rothenberger A, Berghaus U: Clinical and neurobiological findings in children suffering from tic disease following treatment with tiapride. Eur Arch Psychiatry Neurol Sci 1988, 237:223–229.

    Article  CAS  PubMed  Google Scholar 

  40. Jankovic J, Orman J: Tetrabenazine therapy of dystonia, chorea, tics, and other dyskinesias. Neurology 1988, 38:391–394.

    CAS  PubMed  Google Scholar 

  41. Jankovic J, Beach J: Long-term effects of tetrabenazine in hyperkinetic movement disorders. Neurology 1997, 48:358–362.

    CAS  PubMed  Google Scholar 

  42. Hedderick EF, Morris CM, Singer HS: Double-blind, crossover study of clonidine and levetiracetam in Tourette syndrome. Pediatr Neurol 2009, 40:420–425.

    Article  PubMed  Google Scholar 

  43. Smith-Hicks CL, Bridges DD, Paynter NP, Singer HS: A double blind randomized placebo control trial of levetiracetam in Tourette syndrome. Mov Disord 2007, 22:1764–1770.

    Article  PubMed  Google Scholar 

  44. Marras C, Andrews D, Sime E, Lang AE: Botulinum toxin for simple motor tics: a randomized, double-blind, controlled clinical trial. Neurology 2001, 56:605–610.

    CAS  PubMed  Google Scholar 

  45. Visser-Vandewalle V, Temel Y, Boon P, et al.: Chronic bilateral thalamic stimulation: a new therapeutic approach in intractable Tourette syndrome: a report of three cases. J Neurosurg 2003, 99(6):1094–1100.

    Article  PubMed  Google Scholar 

  46. Diederich NJ, Kalteis K, Stamenkovic M, et al.: Efficient internal pallidal stimulation in Gilles de la Tourette syndrome: a case report. Mov Disord 2005, 20:1496–1499.

    Article  PubMed  Google Scholar 

  47. Flaherty AW, Williams ZM, Amirnovin R, et al.: Deep brain stimulation of the anterior internal capsule for the treatment of Tourette syndrome: technical case report. Neurosurgery 2005, 57(Suppl):E403.

    Article  PubMed  Google Scholar 

  48. Servello D, Porta M, Sassi M, et al.: Deep brain stimulation in 18 patients with severe Gilles de la Tourette syndrome refractory to treatment: the surgery and stimulation. J Neurol Neurosurg Psychiatry 2008, 79:136–142.

    Article  CAS  PubMed  Google Scholar 

  49. •• Welter M-L, Mallet L, Houeto J-L, et al.: Internal pallidal and thalamic stimulation in patients with Tourette syndrome. Arch Neurol 2008, 65:952–957. This was the first randomized, double-blind study (albeit in a very small number of patients) to demonstrate the efficacy of DBS in TS.

    Article  PubMed  Google Scholar 

  50. Mink JW, Walkup J, Frey KA, et al.: Patient selection and assessment recommendations for deep brain stimulation in Tourette syndrome. Mov Disord 2006, 21:1831–1838.

    Article  PubMed  Google Scholar 

Download references

Disclosure

No potential conflict of interest relevant to this article was reported.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Thomas E. Kimber.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kimber, T.E. An Update on Tourette Syndrome. Curr Neurol Neurosci Rep 10, 286–291 (2010). https://doi.org/10.1007/s11910-010-0118-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11910-010-0118-2

Keywords

Navigation